Specialties
Neurology Billing and Coding Services
Neurology practices bill complex visits along with diagnostic testing and drug-based treatments that payers review closely. We code each test by the number of nerves or hours recorded, track drug units and wastage, and obtain authorizations before injections and infusions.
What makes neurology billing different?
Neurology combines complex E/M visits with diagnostic tests whose codes depend on how much was studied, such as the number of nerve conduction studies or the length of an EEG, and with drug treatments billed by unit. Botulinum toxin and infusion therapies usually need prior authorization, and Medicare requires modifiers that report discarded or unused drug from single-dose vials.
Common challenges
Where Neurology claims run into trouble
Test-specific coding
Nerve conduction codes depend on the number of studies, and EEG codes on duration and monitoring type.
Drug units and wastage
Botulinum toxin and infusion drugs are billed by unit, with JW or JZ modifiers for single-dose vials.
Authorizations
Botulinum toxin, infusion therapies and imaging usually require prior authorization.
Complex visits
Chronic and multi-condition visits need medical decision making documented to support the E/M level.
Codes and rules
Codes we work with every day
A reference list, not a complete code set. Payer contracts and coverage policies decide how each code is paid.
95816, 95819
Routine EEG, awake and drowsy, and awake and asleep
Longer monitoring uses separate codes.
95700 to 95726
Long-term EEG setup, monitoring and interpretation
Codes depend on duration and whether video is recorded.
95907 to 95913
Nerve conduction studies by number of studies
Count each nerve study performed.
95885 to 95887
Needle EMG performed with nerve conduction studies
Add-on codes billed with NCS codes.
64615, J0585
Chemodenervation for chronic migraine and onabotulinumtoxinA per unit
Units billed must match the documented dose.
JW, JZ
Drug amount discarded and no amount discarded modifiers
Required by Medicare on drugs from single-dose containers.
| Code or modifier | What it covers | Billing note |
|---|---|---|
| 95816, 95819 | Routine EEG, awake and drowsy, and awake and asleep | Longer monitoring uses separate codes. |
| 95700 to 95726 | Long-term EEG setup, monitoring and interpretation | Codes depend on duration and whether video is recorded. |
| 95907 to 95913 | Nerve conduction studies by number of studies | Count each nerve study performed. |
| 95885 to 95887 | Needle EMG performed with nerve conduction studies | Add-on codes billed with NCS codes. |
| 64615, J0585 | Chemodenervation for chronic migraine and onabotulinumtoxinA per unit | Units billed must match the documented dose. |
| JW, JZ | Drug amount discarded and no amount discarded modifiers | Required by Medicare on drugs from single-dose containers. |
CPT is a registered trademark of the American Medical Association.
How we help
How we support Neurology practices
Prior Authorization
Botulinum toxin, infusion and imaging authorizations requested and tracked by dose and date.
Medical Coding
EEG, EMG and nerve conduction codes checked against the study report.
Medical Billing
Drug units and JW or JZ modifiers applied on every injectable claim.
Denial Management
Medical necessity and frequency denials for testing and injections appealed.
How we measure it
The numbers we report for Neurology practices
Reported monthly by payer and provider. Industry references are published figures, not guarantees. Your own baseline comes from the free audit.
Initial Denial Rate
Share of submitted claims denied on first adjudication, counted by claim volume under the HFMA Claim Integrity Task Force definition.
Industry reference: Under 5% is best practice; 41% of providers report 10% or higher (Experian Health, 2025)
First-Pass Resolution Rate
Share of claims paid on the first submission with no follow-up, appeal, or resubmission. Clean claim rate measures acceptance; this measures payment.
Industry reference: 90% or higher is the commonly cited target
A/R Over 90 Days
Share of total outstanding A/R that is more than 90 days past the date of service.
Industry reference: 12% to 15% (MGMA range) (MGMA via ModMed)
Neurology billing questions
What are the JW and JZ modifiers?
How are nerve conduction studies coded?
Does Botox for migraine need prior authorization?
Who bills a long-term EEG done in the hospital?
See where your Neurology revenue cycle stands
Request a free 90-day audit. We review your claims, denials and A/R aging under a signed BAA and send a line-item report in 5 to 7 business days.